home / stock / snyr / snyr quote
Last: | $1.61 |
---|---|
Change Percent: | 4.32% |
Open: | $1.77 |
Close: | $1.61 |
High: | $1.825 |
Low: | $1.55 |
Volume: | 138,240 |
Last Trade Date Time: | 04/25/2025 03:40:13 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$1.61 | $1.77 | $1.61 | $1.825 | $1.55 | 138,240 | 04-25-2025 |
$1.85 | $1.84 | $1.85 | $1.91 | $1.645 | 161,484 | 04-24-2025 |
$1.92 | $2.33 | $1.92 | $2.33 | $1.92 | 141,064 | 04-23-2025 |
$2.36 | $2.57 | $2.36 | $2.57 | $2.22 | 176,054 | 04-22-2025 |
$2.68 | $2.28 | $2.68 | $2.73 | $2.17 | 332,179 | 04-21-2025 |
$2.49 | $2.42 | $2.49 | $2.73 | $2.4 | 332,916 | 04-18-2025 |
$2.49 | $2.42 | $2.49 | $2.73 | $2.4 | 332,916 | 04-17-2025 |
$2.5 | $2.4 | $2.5 | $2.58 | $2.23 | 1,149,706 | 04-16-2025 |
$2.2 | $3.89 | $2.2 | $4.08 | $2.06 | 63,525,279 | 04-15-2025 |
$1.79 | $1.75 | $1.79 | $2 | $1.72 | 256,570 | 04-14-2025 |
$1.7832 | $1.7 | $1.7832 | $2.16 | $1.7 | 21,603 | 04-11-2025 |
$1.75 | $1.82 | $1.75 | $2.19 | $1.64 | 112,681 | 04-10-2025 |
$1.79 | $2.01 | $1.79 | $2.2 | $1.625 | 63,228 | 04-09-2025 |
$2 | $1.97 | $2 | $2.45 | $1.3 | 117,673 | 04-08-2025 |
$2.0313 | $2.16 | $2.0313 | $2.43 | $1.8701 | 88,106 | 04-07-2025 |
$2.295 | $2.28 | $2.295 | $2.4299 | $2.15 | 59,326 | 04-04-2025 |
$2.22 | $2.6426 | $2.22 | $2.6426 | $2.22 | 19,169 | 04-03-2025 |
$2.53 | $2.36 | $2.53 | $2.66 | $2.36 | 17,098 | 04-02-2025 |
$2.575 | $2.43 | $2.575 | $2.85 | $2.3696 | 15,495 | 04-01-2025 |
$2.35 | $2.51 | $2.35 | $2.894 | $1.95 | 25,445 | 03-31-2025 |
News, Short Squeeze, Breakout and More Instantly...
Synergy CHC Corp. Company Name:
SNYR Stock Symbol:
NASDAQ Market:
4.32% G/L:
$1.61 Last:
138,240 Volume:
$1.77 Open:
$1.61 Close:
Synergy CHC Corp. Website:
2025-04-15 10:34:57 ET DENVER, Colo., Apr 15, 2025 ( 247marketnews.com ) -Today’s top news and trades include weight loss and super fibers. MetaVia (NASDAQ:MTVA) unveiled Phase 1 MAD trial results for DA-1726, its novel 3:1 ratio GLP-1/glucagon dual receptor agonist aimed at ...
Spire Global Inc. Class A (SPIR) is expected to report $-0.97 for Q4 2024 CaliberCos Inc. (CWD) is expected to report $-0.04 for Q4 2024 Progress Software Corporation (PRGS) is expected to report $0.79 for Q1 2025 Nuvve Holding Corp. (NVVE) is expected to report for quarter end 2024-1...
H. I. S. Co. Ltd (HISJF) is expected to report for quarter end 2025-01-31 Biofrontera Inc. (BFRI) is expected to report $0.02 for Q4 2024 Real Messenger Corporation (RMSG) is expected to report for quarter end 2024-12-31 Tivic Health Systems Inc. (TIVC) is expected to report for quart...